Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Niagen Bioscience (NAGE) over the last 13 years, with Q3 2025 value amounting to -$233000.0.

  • Niagen Bioscience's Other Working Capital Changes rose 4330.9% to -$233000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$713000.0, marking a year-over-year decrease of 1707.72%. This contributed to the annual value of -$732000.0 for FY2024, which is 1366.46% down from last year.
  • Per Niagen Bioscience's latest filing, its Other Working Capital Changes stood at -$233000.0 for Q3 2025, which was up 4330.9% from -$75000.0 recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Other Working Capital Changes registered a high of $2.8 million during Q3 2022, and its lowest value of -$1.4 million during Q4 2022.
  • For the 5-year period, Niagen Bioscience's Other Working Capital Changes averaged around -$22611.1, with its median value being -$156000.0 (2021).
  • Per our database at Business Quant, Niagen Bioscience's Other Working Capital Changes skyrocketed by 20326.09% in 2022 and then tumbled by 123913.04% in 2023.
  • Niagen Bioscience's Other Working Capital Changes (Quarter) stood at $202000.0 in 2021, then crashed by 787.62% to -$1.4 million in 2022, then surged by 108.86% to $123000.0 in 2023, then plummeted by 434.15% to -$411000.0 in 2024, then soared by 43.31% to -$233000.0 in 2025.
  • Its Other Working Capital Changes was -$233000.0 in Q3 2025, compared to -$75000.0 in Q2 2025 and -$405000.0 in Q1 2025.